Q3 2019 Pulse Biosciences Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Pulse Biosciences' Third Quarter 2019 Investor and Analyst Update Conference Call. As a reminder, this conference call is being recorded. I'd now like to turn the conference over to your host, Brian Dow, Pulse Biosciences Senior Vice President and Chief Financial Officer. Please go ahead.
Thank you, operator, and good afternoon everyone. Welcome to Pulse Biosciences Quarterly Investor and Analyst Update Call. Joining me on the call today are Darrin Uecker, our President and Chief Executive Officer; and Ed Ebbers, our Executive Vice President and General Manager of Dermatology.
Our comments and responses to your questions during today's call reflect management's views as of today, November 7, 2019, only and will include forward-looking statements. These include statements regarding our plans and expectations relating to regulatory clearance, including the process and expected outcomes, our commercial, operational, scientific, clinical and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |